Indian Biosimilars Industry Poised for Immense Growth
As per our new research report, “Global Biosimilars Market Analysis”, the acceptability of biosimilars is very high in the Indian domestic market. Factors that are working favorably for Indian biosimilar companies are the relative cost advantage of biosimilar development compared to their competitors elsewhere; hence reducing appeal of imported biosimilars and relatively lowering of regulatory requirements for establishing bioequivalence.
View full press release